Hope Funds for Cancer Research

Analysis

Hope Funds for Cancer Research is a registered charity in United States, based in Newport, RI. It received its IRS tax-exemption ruling in January 2007, 19 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Hope Funds for Cancer Research reported income of $752k and spending of $517k, leaving 31% of income unspent that year. Across the 5 years on record, from December 2019 to December 2023, income grew from $613k to $752k (+23%), an average of +5.2% a year. The sharpest change came in the year to December 2023, when income rose by 137%. Over the whole period it spent 104% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Hope Funds for Cancer Research sits at the 61st percentile: it is larger than about 60% of them. Against every charity in United States with reported income it ranks in the 76th percentile, and in the 72nd percentile within RI. Charities of a similar size with the same main cause include Acoustic Neuroma Association ($752k), Emmco West Inc ($752k) and Bridgeton Ems Inc ($752k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 113% of the total. At year end it held assets of $1.0m against liabilities of $400k, net assets of $631k.